Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lynn Henry

Showing results (11-20 of 195) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
The Power of the Placebo in Symptom ManagementN Lynn Henry, Jennifer J Griggs
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Adjuvant endocrine therapy in premenopausal women with breast cancerKunal C Kadakia, N Lynn Henry
Oncology (Williston Park, N.Y.)|June 24, 2009
Complexities of adjuvant endocrine therapy in young premenopausal womenN Lynn Henry, Jennifer J Griggs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy?N Lynn Henry, Daniel F Hayes
Breast Cancer Research and Treatment|October 12, 2011
Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivorsN Lynn Henry, Daniel J Clauw
Oncology (Williston Park, N.Y.)|December 18, 2007
Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancerN Lynn Henry, Daniel F Hayes
The Oncologist|June 24, 2006
Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancerN Lynn Henry, Daniel F Hayes
Journal of the National Cancer Institute|October 13, 2018
Surveillance After Treatment of Localized Breast Cancer: Time for Reappraisal?Joseph A Sparano, N Lynn Henry
Current Oncology Reports|March 3, 2017
Extended Endocrine Therapy: Is 5 Years Enough?Manali A Bhave, N Lynn Henry
Journal of the National Cancer Institute|September 21, 2022
Unintended Negative Consequences of Managing Chemotherapy ToxicityN Lynn Henry, Patricia A Ganz
Pageof 20

Showing results (11-20 of 195) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2015
The Power of the Placebo in Symptom ManagementN Lynn Henry, Jennifer J Griggs
Clinical Advances in Hematology & Oncology : H&O|April 9, 2016
Adjuvant endocrine therapy in premenopausal women with breast cancerKunal C Kadakia, N Lynn Henry
Oncology (Williston Park, N.Y.)|June 24, 2009
Complexities of adjuvant endocrine therapy in young premenopausal womenN Lynn Henry, Jennifer J Griggs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy?N Lynn Henry, Daniel F Hayes
Breast Cancer Research and Treatment|October 12, 2011
Thinking beyond the tumor to better understand chronic symptoms in breast cancer survivorsN Lynn Henry, Daniel J Clauw
Oncology (Williston Park, N.Y.)|December 18, 2007
Use of gene-expression profiling to recommend adjuvant chemotherapy for breast cancerN Lynn Henry, Daniel F Hayes
The Oncologist|June 24, 2006
Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancerN Lynn Henry, Daniel F Hayes
Journal of the National Cancer Institute|October 13, 2018
Surveillance After Treatment of Localized Breast Cancer: Time for Reappraisal?Joseph A Sparano, N Lynn Henry
Current Oncology Reports|March 3, 2017
Extended Endocrine Therapy: Is 5 Years Enough?Manali A Bhave, N Lynn Henry
Journal of the National Cancer Institute|September 21, 2022
Unintended Negative Consequences of Managing Chemotherapy ToxicityN Lynn Henry, Patricia A Ganz
Pageof 20